Esketamine for treatment-resistant depression [ID1414]

This appeal hearing will hear appeals against the Final Appraisal Document for the above technology by the following organisations:

  • Janssen-Cilag Ltd
  • Royal College of Psychiatrists

 The appeal panel will convene on Wednesday 27 July 2022 at 10:00am via Zoom to hear oral representations from the appellants. 


This page was last updated: